Evolution of previous sarcoidosis under type 1 interferons given for severe associated disease

European Respiratory Journal

Volumn 25, Issue 3, 2005, Pages 570-573

  Charlier, C ^a   Nunes, H ^a   Trinchet, J C ^b   Roullet, E ^c   Mouthon, L ^a   Beaugrand, M ^b   Valeyre, Dominique ^a  

^a AVICENNE HOSPITAL   (France)

^b HÔPITAL JEAN VERDIER   (France)

^c HÔPITAL TENON   (France)

Author keywords

Granulomatosis; Hepatitis B virus; Hepatitis C virus; Interferon and ; Multiple sclerosis; Sarcoidosis

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; BETA1A INTERFERON; GAMMA INTERFERON; HYDROXYCHLOROQUINE; INTERFERON; PREDNISONE; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG INDICATION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HELPER CELL; HUMAN; LUNG SARCOIDOSIS; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PATHOGENESIS; PATIENT MONITORING; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME; VIRUS HEPATITIS;

ADULT; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; INTERFERON TYPE I; INTERFERON-ALPHA; INTERFERON-BETA; MALE; RECURRENCE; SARCOIDOSIS; TREATMENT OUTCOME;

EID: 14744301150     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00141703     Document Type: Article

References (23)

1. Baughman RP, Lower EE, Du Bois RM. Sarcoidosis. Lancet 2003; 361: 1111-1118.
2. Bäumer I, Zissel G, Schlaak M, Müller-Quernheim J. Th1/Th2 cell distribution in pulmonary sarcoidosis. Am J Respir Cell Mol Biol 1997; 16: 171-177.
3. Moller DR. Pulmonary fibrosis of sarcoidosis. New approaches, old ideas. Am J Respir Cell Mol Biol 2003; 29: Suppl. 3, S37-S41.
4. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997; 336: 1224-1234.
5. Flamm SL. Chronic hepatitis C virus infection. JAMA 2003; 289: 2413-2417.
6. Degos F, Christidis C, Ganne-Carrie N, et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 2000; 47: 131-136.
7. Ganem D, Prince AE. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004; 350: 1118-1129.
8. Druker BJ, Sawyers CL, Capdeville R, Ford JM, Baccarani M, Goldman JM. Chronic myelogenous leukemia. Hematology 2001: 87-112.
9. O'Connor P. Key issues in the diagnosis and treatment of multiple sclerosis. Neurology 2002; 59: 1-33.
10. Abdi EA, Nguyen GK, Ludwig RN, Dickout WJ. Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma. Cancer 1987; 59: 896-900.
11. Leclerc S, Myers RP, Moussalli J, Herson S, Poynard T, Benveniste O. Sarcoidosis and interferon therapy: report of five cases and review of the literature. Eur J Intern Med 2003; 14: 237-243.
12. Miwa H, Furuya T, Tanaka S, Mizuno Y. Neurosarcoidosis associated with interferon therapy. Eur Neurol 2001; 45: 288-289.
13. Bobbio-Pallavicini E, Valsecchi C, Tacconi F, Moroni M, Porta. C. Sarcoidosis following β-interferon therapy for multiple myeloma. Sarcoidosis 1995; 12: 140-142.
14. Mehta Cl, Tyler RJ, Cripps DJ. Granulomatous dermatitis with focal sarcoidal features associated with recombinant interferon β-1b injections. J Am Acad Dermatol 1998; 39: 1024-1028.
15. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
16. Biron CA. Interferons α and β as immune regulator. A new look. Immunity 2001; 14: 661-664.
17. Nakajima M, Kubota Y, Miyashita N, Niki Y, Matsushima T, Manabe T. Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C. Intern Med 1996; 35: 376-379.
18. Li SD, Yong S, Srinivas D, Van Thiel DH. Reactivation of sarcoidosis during interferon therapy. J Gastroenterol 2002; 37: 50-54.
19. Ohhata I, Ochi T, Kurebayashi S, Matusani H, Kikui M. A case of subcutaneous sarcoid nodules induced by interferon-alpha. Nihon Kyobu Shikkan Gakkai Zasshi 1994; 32: 996-1000.
20. Luers C, Sudhop T, Spengler U, Berthold HK. Improvement of sarcoidosis under therapy with interferon-alpha 2b for chronic hepatitis B virus infection. J Hepatol 1999; 30: 347.
21. Nguyen KB, Cousens LP, Doughty LA, Pien GC, Durbin JE, Biron CA. Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat Immunol 2000; 1: 70-76.
22. Mizuguchi J, Takeuchi M, Usui M. Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveorefinitis. Arch Immunol Ther Exp (Warsz) 2002; 50: 243-254.
23. Feng J, Misu T, Fujihara K, et al. Th1/Th2 balance and HTLV-I proviral load in HAM/TSP patients treated with interferon-alpha. J Neuroimmunol 2004; 151: 189-194.